English

Sanolium AB interim report, July - September 2021

Report this content

Q3, July - September 2021

  • Revenue amounted to 191.4 (158.5) MSEK in the third quarter, representing a growth of 20.8%

  • Adjusted EBITDA amounted to 75.4 (43.7) MSEK, representing a growth of 72.6%

  • Income before tax 26.6 MSEK (-4.5)

  • Net income per share 0.14 SEK (neg)

CEO’s Comments

As the Covid-19 situation has improved towards the end of the quarter, the business has begun to normalize. Our direct interactions with our customers remain at a modest level compared to previously however we see increased customer activity. We continue to make progress across the organisation and are now very focused on improving Cambio ́s strategic focus, operational efficiency and productivity.

During the third quarter the Covid-related vaccinations peaked in Sweden. MittVaccin is now an established part of the vaccination solutions in the Swedish market with more than 25% of all Covid- vaccinations carried out via the MittVaccin solution.

Cambio is continuously focused on strengthening the partnerships with our customers to support them in their important work in the health- and social care sectors and to become even more efficient.

This disclosure contains information that Sanolium is obliged to make public pursuant to the Swedish Securities Markets Act (2007:528). The information was submitted for publication, through the agency of the contact person, on 30-11-2021 16:48 CET.

For further information, please contact: 

Rami Avidan
CEO
+46 7 0 79 34 83 
rami.avidan@cambio.se

Niklas Berglund
CFO
+46 70 564 55 27
niklas.berglund@cambio.se

Sanolium AB, parent of the Cambio Group (“Cambio” or “the Company”) operating entities, is an e-health company providing comprehensive IT solutions to improve healthcare and patient safety. Cambio is one of the largest suppliers in Scandinavia and a growing player in the European market, with more than 170,000 users across regions and municipalities, general and university hospitals, health centers and specialist units. Cambio has offices in Sweden, Denmark, United Kingdom and Sri Lanka.

Subscribe

Documents & Links